Bedside assessment of sarcopenia in hospitalized patients with liver cirrhosis: Magnitude and clinical implications

Boutin RD, Yao L, Canter RJ, Lenchik L. Sarcopenia: current concepts and imaging implications. AJR Am J Roentgenol. 2015;205:W255–66.

Article  PubMed  Google Scholar 

Kim G, Kang SH, Kim MY, Baik SK. Prognostic value of sarcopenia in patients with liver cirrhosis: a systematic review and meta-analysis. PLoS One. 2017;12:e0186990.

Article  PubMed  PubMed Central  Google Scholar 

Puri P, Dhiman RK, Taneja S, et al. Nutrition in chronic liver disease: consensus statement of the Indian National Association for Study of the Liver. J Clin Exp Hepatol. 2021;11:97–143.

Dhaliwal A, Armstrong MJ. Sarcopenia in cirrhosis: a practical overview. Clin Med. 2020;20:489–92. https://www.rcpjournals.org/content/clinmedicine/20/5/489

Kumar R, Prakash SS, Priyadarshi RN, Anand U. Sarcopenia in chronic liver disease: a metabolic perspective. J Clin Transl Hepatol. 2022;10:1213–22. http://www.xiahepublishing.com/2310-8819/JCTH-2022-00239

Cruz-Jentoft AJ, Bahat G, Bauer J,  et al. Sarcopenia: revised European consensus on definition and diagnosis. Age Ageing. 2019;48:16–31.

Article  PubMed  Google Scholar 

Nijholt W, Scafoglieri A, Jager-Wittenaar H, Hobbelen JSM, van der Schans CP. The reliability and validity of ultrasound to quantify muscles in older adults: a systematic review. J Cachexia Sarcopenia Muscle. 2017;8:702–12.

Article  PubMed  PubMed Central  Google Scholar 

Mahmoud H, Kamal H, El-Liethy N, Hassan M, Said E. Value of ultrasound in grading the severity of sarcopenia in patients with hepatic cirrhosis. Egypt J Radiol Nucl Med. 2021;52:1–14. https://ejrnm.springeropen.com/articles/10.1186/s43055-021-00638-3

Dhariwal S, Roy A, Taneja S, et al. Assessment of sarcopenia using muscle ultrasound in patients with cirrhosis and sarcopenic obesity (AMUSE STUDY). J Clin Gastroenterol. 2023;57:841–7.

Article  CAS  PubMed  Google Scholar 

Obesity | National Health Portal Of India [Internet]. [cited 2022 Feb 21]. Available from: https://www.nhp.gov.in/disease/non-communicable-disease/obesity

Premkumar M, Anand AC. Overview of complications in cirrhosis. J Clin Exp Hepatol. 2022;12:1150–74.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Benjamin J, Shasthry V, Kaal CR, et al. Characterization of body composition and definition of sarcopenia in patients with alcoholic cirrhosis: a computed tomography based study. Liver Int. 2017;37:1668–74.

Kumar V, Benjamin J, Shasthry V, et al. Sarcopenia in cirrhosis: fallout on liver transplantation. J Clin Exp Hepatol. 2020;10:467–76.

Article  PubMed  Google Scholar 

Hanai T, Shiraki M, Nishimura K, et al. Sarcopenia impairs prognosis of patients with liver cirrhosis. Nutrition. 2015;31:193-9.

Google Scholar 

Montano-Loza AJ, Meza-Junco J, Prado CMM, et al. Muscle wasting is associated with mortality in patients with cirrhosis. Clin Gastroenterol Hepatol. 2012;10:173.e1.

Tandon P, Ney M, Irwin I, et al. Severe muscle depletion in patients on the liver transplant wait list: its prevalence and independent prognostic value. Liver Transplant. 2012;18:1209–16.

Ebadi M, Bhanji RA, Mazurak VC, Montano-Loza AJ. Sarcopenia in cirrhosis: from pathogenesis to interventions. J Gastroenterol. 2019;54:845–59. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6759678/

DiMartini A, Cruz RJ, Dew MA, et al. Muscle mass predicts outcomes following liver transplantation. Liver Transplant. 2013;19:1172–80.

Google Scholar 

Durand F, Buyse S, Francoz C, et al. Prognostic value of muscle atrophy in cirrhosis using psoas muscle thickness on computed tomography. J Hepatol. 2014;60:1151–7.

Article  PubMed  Google Scholar 

Montano-Loza AJ, Duarte-Rojo A, Meza-Junco J, et al. Inclusion of sarcopenia within MELD (MELD-sarcopenia) and the prediction of mortality in patients with cirrhosis. Clin Transl Gastroenterol. 2015;6:e102.

Article  PubMed  PubMed Central  Google Scholar 

Wijarnpreecha K, Werlang M, Panjawatanan P, et al. Association between sarcopenia and hepatic encephalopathy: a systematic review and meta-analysis. Ann Hepatol. 2020;19:245–50.

Article  CAS  PubMed  Google Scholar 

Dolz C, Raurich JM, Ibáñez J, Obrador A, Marsé P, Gayá J. Ascites increases the resting energy expenditure in liver cirrhosis. Gastroenterology. 1991;100:738–44.

Article  CAS  PubMed  Google Scholar 

Dasarathy S. Myostatin and beyond in cirrhosis: all roads lead to sarcopenia. J Cachexia Sarcopenia Muscle. 2017;8:864–9.

Article  PubMed  PubMed Central  Google Scholar 

Merli M, Lucidi C, Giannelli V, et al. Cirrhotic patients are at risk for health care-associated bacterial infections. Clin Gastroenterol Hepatol.2010;8:979–85.

Google Scholar 

Mauro E, Crespo G, Martinez-Garmendia A, et al. Cystatin C and sarcopenia predict acute on chronic liver failure development and mortality in patients on the liver transplant waiting list. Transplantation. 2020;104:e188–98.

Article  CAS  PubMed  Google Scholar 

Khan S, Benjamin J, Maiwall R, et al. Sarcopenia is the independent predictor of mortality in critically ill patients with cirrhosis. J Clin Transl Res. 2022;8:200–8. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9260346/

Ogawa M, Matsumoto T, Harada R, et al. Reliability and validity of quadriceps muscle thickness measurements in ultrasonography: a comparison with muscle mass and strength. Prog Rehabil Med. 2023;8:20230008.

Article  PubMed  PubMed Central  Google Scholar 

Hadda V, Kumar R, Dhungana A, Khan MA, Madan K, Khilnani GC. Inter- and intra-observer variability of ultrasonographic arm muscle thickness measurement by critical care physicians. J Postgrad Med. 2017;63:157–61.

Article  CAS  PubMed  PubMed Central  Google Scholar 

留言 (0)

沒有登入
gif